Tejas Patil, MD, is a medical oncologist. Lisa Ferrigno, MD, MPH, FACS, is a trauma surgeon. Working with lung cancer patients at University of Colorado Cancer Center, they both, independently, ...
University of Colorado (CU) Cancer Center member Tejas Patil, MD, is one of three researchers to receive a combined $1 million grant from the Hamoui Foundation and LUNGevity Foundation to study ...
The fully human HER3 monoclonal antibody seribantumab produced durable responses in ovarian and other solid tumors with NRG1 fusions across multiple cancer subtypes and fusion partners, according to ...
Tejas Patil, MD, observes how groundbreaking data presented at ASCO 2024 is shaping the management of patients with advanced NSCLC. For ALK-rearranged NSCLC, the CROWN trial supports lorlatinib as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results